This is despite the relative clinical outcomes, with tumours amplified for two or three genes doing significantly worse than those amplified for PDGFRA alone or harbouring normal copy number (p = 0.0159, log-rank test) (Figure 3C). Here, PDGFRA is linked to neoplasm.